Sinotherapeutics

Sinotherapeutics EBIT per Share

The EBIT per Share of Sinotherapeutics (688247.SS) as of Oct 13, 2026 is 0.14 CNY. In the previous year, EBIT per Share was 0.28 CNY — a change of -51.87% (lower).

EBIT per Share

0.14CNY

YoY

-51.87%

Last updated:

EBIT per Share of Sinotherapeutics is 2025 0.14 CNY. EBIT per Share of Sinotherapeutics was 2024 0.28 CNY. It decreases by -51.87% lower compared to the previous year.

The Sinotherapeutics EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2019
-0.03 CNY
Jan 1, 2020
0.29 CNY
Jan 1, 2021
0.27 CNY
Jan 1, 2022
0.15 CNY
Jan 1, 2023
0.12 CNY
Jan 1, 2024
0.28 CNY
Jan 1, 2025
0.14 CNY
The Sinotherapeutics EBIT per Share history
YEAREBIT per ShareYoY
0.14CNY-51.87%
0.28CNY+142.73%
0.12CNY-22.04%
0.15CNY-43.83%
0.27CNY-8.78%
0.29CNY-1,076.60%
-0.03CNY—
Access this data via the Eulerpool API
Get Free API Key

Sinotherapeutics Stock analysis

What does Sinotherapeutics do? Sinotherapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sinotherapeutics stock

EBIT per Share of Sinotherapeutics is 0.14 CNY in 2025.

EBIT per Share of Sinotherapeutics changed from 0.28 CNY to 0.14 CNY, representing a -51.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Sinotherapeutics since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Sinotherapeutics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sinotherapeutics